Now Reading: India pharma exports up 6.8% to $8.1 bn in Q1 FY27
-
01
India pharma exports up 6.8% to $8.1 bn in Q1 FY27
India's pharmaceutical exports rose 6.8% to $8.1 billion in the April-June quarter of FY27, driven by strong overseas demand for vaccines and bulk drugs, the Pharmaceuticals Export Promotion Council of India (Pharmexcil)…
The Story in Brief
India's pharmaceutical exports rose 6.8% to $8.1 billion in the April-June quarter of FY27, driven by strong overseas demand for vaccines and bulk drugs, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) said on Wednesday. Vaccine exports surged 35.68% to $390 million, the fastest growth segment, while bulk drugs and drug intermediates rose 13.84% to $1.36 billion. Drug formulations and biologicals, the largest category, grew 4.14% to $5.98 billion, accounting for nearly 74% of total pharma exports.
The United States remained India's top country-level market with $2.5 billion in shipments, followed by Brazil, the UK, the Netherlands and France. NAFTA, Europe, Africa and Latin America together accounted for about 75% of exports. Pharmexcil chairman Namit Joshi said the sector combined scale in established markets with gains across wider geographies despite geopolitical turbulence.
The Indian Opinion
The media narrative that US tariffs would cripple India's pharma exports has been contradicted by Q1 data showing 6.8% growth and record vaccine sales. Yet the US remains the largest buyer at $2.5 billion, and tariffs could still bite. Watch whether bulk drug exports, which jumped nearly 14% this quarter, can sustain that pace without facing protectionist measures.
Sources (2): timesofindia.indiatimes.com, hindustantimes.com
This story was synthesised by AI from the 2 sources linked above.
Updated: this story now draws on 2 sources.
